Midostaurin is a new drug used for the treatment of:
CML
ALL
AML
CLL
Midostaurin : Multitargeted protein kinase inhibitor indicated along with standard cytarabine and daunorubicin for adult with newly diagnosed Acute Myeloid Leukemia (AML) who are FLT3 mutation positive.
JIPMER 2017